BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 10875457)

  • 1. A prospective analysis of patient-reported quality of life after prostate brachytherapy.
    Lee WR; McQuellon RP; McCullough DL
    Semin Urol Oncol; 2000 May; 18(2):147-51. PubMed ID: 10875457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early quality of life assessment in men treated with permanent source interstitial brachytherapy for clinically localized prostate cancer.
    Lee WR; McQuellon RP; Case LD; deGuzman AF; McCullough DL
    J Urol; 1999 Aug; 162(2):403-6. PubMed ID: 10411047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A preliminary analysis of health-related quality of life in the first year after permanent source interstitial brachytherapy (PIB) for clinically localized prostate cancer.
    Lee WR; McQuellon RP; Harris-Henderson K; Case LD; McCullough DL
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):77-81. PubMed ID: 10656376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective assessment of patient-reported long-term urinary morbidity and associated quality of life changes after 125I prostate brachytherapy.
    Stone NN; Stock RG
    Brachytherapy; 2003; 2(1):32-9. PubMed ID: 15062161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life in men receiving prostate brachytherapy on RTOG 98-05.
    Feigenberg SJ; Lee WR; Desilvio ML; Winter K; Pisansky TM; Bruner DW; Lawton C; Morton G; Baikadi M; Sandler H
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):956-64. PubMed ID: 15989995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of long-term quality of life and voiding function of patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer.
    Bradley EB; Bissonette EA; Theodorescu D
    BJU Int; 2004 Nov; 94(7):1003-9. PubMed ID: 15541117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brachytherapy-related dysuria.
    Merrick GS; Butler WM; Wallner KE; Allen Z; Galbreath RW; Lief JH
    BJU Int; 2005 Mar; 95(4):597-602. PubMed ID: 15705087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of transurethral resection of prostate on the quality of life of patients with benign prostatic hyperplasia.
    O'Sullivan M; Murphy C; Deasy C; Iohom G; Kiely EA; Shorten G
    J Am Coll Surg; 2004 Mar; 198(3):394-403. PubMed ID: 14992742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective analysis of long-term quality of life after permanent I-125 brachytherapy for localised prostate cancer.
    Ash D; Bottomley D; Al-Qaisieh B; Carey B; Gould K; Henry A
    Radiother Oncol; 2007 Aug; 84(2):135-9. PubMed ID: 17604140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life after brachytherapy or radical prostatectomy for localized prostate cancer: a prospective longitudinal study.
    Namiki S; Satoh T; Baba S; Ishiyama H; Hayakawa K; Saito S; Arai Y
    Urology; 2006 Dec; 68(6):1230-6. PubMed ID: 17141839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life of patients after permanent prostate brachytherapy in relation to dosimetry.
    Van Gellekom MP; Moerland MA; Van Vulpen M; Wijrdeman HK; Battermann JJ
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):772-80. PubMed ID: 15964707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study of quality of life of patients receiving treatment for prostate cancer.
    Eller LS; Lev EL; Gejerman G; Colella J; Esposito M; Lanteri V; Scheuch J; Munver R; Lane P; Junchaya C; Alves L; Galli B; Watson R; Sawczuk I
    Nurs Res; 2006; 55(2 Suppl):S28-36. PubMed ID: 16601630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life in men treated with carbon ion therapy for prostate cancer.
    Wakatsuki M; Tsuji H; Ishikawa H; Yanagi T; Kamada T; Nakano T; Suzuki H; Akakura K; Shimazaki J; Tsujii H
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1010-5. PubMed ID: 18495370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy.
    Lee WR; Hall MC; McQuellon RP; Case LD; McCullough DL
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):614-23. PubMed ID: 11597800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors for acute and late urinary toxicity after permanent prostate brachytherapy: long-term outcome in 712 consecutive patients.
    Keyes M; Miller S; Moravan V; Pickles T; McKenzie M; Pai H; Liu M; Kwan W; Agranovich A; Spadinger I; Lapointe V; Halperin R; Morris WJ
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1023-32. PubMed ID: 19111402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation.
    Lehrer S; Cesaretti J; Stone NN; Stock RG
    BJU Int; 2006 Nov; 98(5):979-81. PubMed ID: 17034599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective evaluation of quality of life after interstitial brachytherapy for localized prostate cancer.
    Caffo O; Fellin G; Bolner A; Coccarelli F; Divan C; Frisinghelli M; Mussari S; Ziglio F; Malossini G; Tomio L; Galligioni E
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):31-7. PubMed ID: 16765529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of a novel neoadjuvant and adjuvant hormone-deprivation approach on quality of life, voiding function, and sexual function after prostate brachytherapy.
    Miller NL; Bissonette EA; Bahnson R; Wilson J; Theodorescu D
    Cancer; 2003 Mar; 97(5):1203-10. PubMed ID: 12599226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nature and extent of urinary morbidity in relation to prostate brachytherapy urethral dosimetry.
    Neill M; Studer G; Le L; McLean M; Yeung I; Pond G; Crook JM
    Brachytherapy; 2007; 6(3):173-9. PubMed ID: 17681239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.